Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
122 hedge funds and large institutions have $743M invested in Abiomed Inc in 2013 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 57 increasing their positions, 30 reducing their positions, and 13 closing their positions.
90% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 30
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
1% less funds holding
Funds holding: 123 → 122 (-1)
10% less capital invested
Capital invested by funds: $825M → $743M (-$82.5M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
37% less call options, than puts
Call options by funds: $2.74M | Put options by funds: $4.38M
Top Buyers
Top Sellers
ABMD Hedge Fund Activity: Q3 2013 in Review
122 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q3 2013, worth a combined $743M — down 10% from $825M a quarter earlier.
Fund positioning in ABMD was balanced in Q3 2013: 13 funds opened new positions, 13 closed out, 57 added to existing stakes and 30 trimmed.
The largest buyer was Geneva Capital Management, opening a new position worth an estimated $7.68M. The largest seller was Redmile Group, exiting entirely with an estimated $7.03M sold.
- 122 institutional investors held Abiomed Inc (ABMD) as of Q3 2013, down from 123 in Q2 2013.
- Funds reported $743M of Abiomed Inc stock for Q3 2013, down 10% quarter-over-quarter.
- 13 funds opened new Abiomed Inc positions in Q3 2013 and 13 closed out, a net change of 0 holders.
- The largest Abiomed Inc buyer in Q3 2013 was Geneva Capital Management, an estimated $7.68M added.
- The largest Abiomed Inc seller in Q3 2013 was Redmile Group, an estimated $7.03M sold.
Based on aggregated 13F filings for Q3 2013.